Published December 11, 2013 | Version v1
Journal article Metadata-only

Marked radiographic response of a HER-2-overexpressing biliary cancer to trastuzumab

Creators

  • 1. Washington University School of Medicine, Department of Oncology, St Louis, MO (United States)

Description

Trastuzumab is a monoclonal antibody targeting HER-2. HER-2 overexpression has been described in gallbladder cancer and in cholangiocarcinoma. This report describes the first case of a patient with HER-2 overexpressing metastatic gallbladder adenocarcinoma and responding radiographically and biochemically to trastuzumab alone

Availability note (English)

Available from http://dx.doi.org/10.2147/CMAR.S55091; Available from http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3864990

Additional details

Identifiers

URL
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3864990;
DOI
10.2147/CMAR.S55091;

Publishing Information

Journal Title
Cancer Management and Research
Journal Volume
9
Journal Page Range
p. 1-3
ISSN
1179-1322

INIS

Country of Publication
New Zealand
Country of Input or Organization
International Atomic Energy Agency (IAEA)
INIS RN
47001282
Subject category
S62: RADIOLOGY AND NUCLEAR MEDICINE;
Descriptors DEI
BILIARY TRACT; CARCINOMAS; METASTASES; MONOCLONAL ANTIBODIES
Descriptors DEC
ANTIBODIES; DIGESTIVE SYSTEM; DISEASES; NEOPLASMS

Optional Information

Copyright
Copyright (c) 2014 Sorscher. This work is published by Dove Medical Press Limited, and licensed under Creative Commons Attribution #En Dash# Non Commercial (unported, v3.0) License
Notes
PMCID: PMC3864990; PMID: 24376362; PUBLISHER-ID: cmar-6-001; OAI: oai:pubmedcentral.nih.gov:3864990